Tumor Necrosis Factor-Alpha, Interleukin-6, and Interleukin-10 Levels are Altered in Preeclampsia: A Systematic Review and Meta-Analysis
Article first published online: 24 JUN 2013
© 2013 John Wiley & Sons Ltd
American Journal of Reproductive Immunology
Volume 70, Issue 5, pages 412–427, November 2013
How to Cite
Tumor necrosis factor-alpha, interleukin-6 and interleukin-10 levels are altered in preeclampsia: a systematic review and meta-analysis. Am J Reprod Immunol 2013; 70: 412–427, , , , , , .
- Issue published online: 9 OCT 2013
- Article first published online: 24 JUN 2013
- Manuscript Accepted: 19 APR 2013
- Manuscript Received: 3 FEB 2013
- The University of Auckland
- Royal Society of New Zealand
- Faculty of Medical and Health Sciences Research Development Fund
- tumor necrosis factor-alpha
Published reports testing the association between cytokine levels and preeclampsia are conflicting. This comprehensive systematic review and meta-analysis aimed at testing the association between preeclampsia and maternal circulating tumor necrosis factor-alpha (TNF-α), interleukin (IL)-6, and IL-10.
Method of study
A systematic literature search of studies reporting maternal circulating TNF-α, IL-6, and IL-10 in women with preeclampsia and normotensive pregnant women was conducted yielding 41, 28, and 12 eligible reports, respectively.
Both mild preeclampsia and severe preeclampsia were associated with elevated TNF-α [mean difference (MD) = 7.34 pg/mL, 95% CI 5.02–9.66 and MD = 7.91 pg/mL, 95% CI 4.72–11.10, respectively] and IL-6 (MD = 61.01 pg/mL, 95% CI 14.24–107.77 and MD = 28.54 pg/mL, 95% CI 15.90–41.17, respectively) in the third trimester. Preeclampsia was also associated with elevated levels of IL-10 (MD = 5.54, 95% CI 0.69–10.38). The systematic review of studies reporting median data was in consensus with the parametric data.
This systematic review and meta-analysis with accompanying summary of non-parametric data shows elevated maternal circulating TNF-α, IL-6, and IL-10 levels in preeclampsia.